bromocriptine mesylate

Generic: bromocriptine mesylate

Labeler: padagis us llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bromocriptine mesylate
Generic Name bromocriptine mesylate
Labeler padagis us llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

bromocriptine mesylate 2.5 mg/1

Manufacturer
Padagis US LLC

Identifiers & Regulatory

Product NDC 0574-0106
Product ID 0574-0106_3a655bc4-d44e-4dd2-a951-211d8484f788
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077646
Listing Expiration 2026-12-31
Marketing Start 2014-04-01

Pharmacologic Class

Classes
ergolines [cs] ergot derivative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05740106
Hyphenated Format 0574-0106

Supplemental Identifiers

RxCUI
197411
UNII
FFP983J3OD

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bromocriptine mesylate (source: ndc)
Generic Name bromocriptine mesylate (source: ndc)
Application Number ANDA077646 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE, PLASTIC (0574-0106-01)
  • 30 TABLET in 1 BOTTLE, PLASTIC (0574-0106-03)
source: ndc

Packages (2)

0574-0106-01 100 TABLET in 1 BOTTLE, PLASTIC (0574-0106-01) 0574-0106-03 30 TABLET in 1 BOTTLE, PLASTIC (0574-0106-03)

Ingredients (1)

bromocriptine mesylate (2.5 mg/1)

Linked Drug Pages (1)

Bromocriptine mesylate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a655bc4-d44e-4dd2-a951-211d8484f788", "openfda": {"unii": ["FFP983J3OD"], "rxcui": ["197411"], "spl_set_id": ["0ee2da00-faf8-4c51-a696-9462fa4f6050"], "manufacturer_name": ["Padagis US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (0574-0106-01)", "package_ndc": "0574-0106-01", "marketing_start_date": "20140401"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (0574-0106-03)", "package_ndc": "0574-0106-03", "marketing_start_date": "20140401"}], "brand_name": "Bromocriptine mesylate", "product_id": "0574-0106_3a655bc4-d44e-4dd2-a951-211d8484f788", "dosage_form": "TABLET", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "0574-0106", "generic_name": "Bromocriptine mesylate", "labeler_name": "Padagis US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bromocriptine mesylate", "active_ingredients": [{"name": "BROMOCRIPTINE MESYLATE", "strength": "2.5 mg/1"}], "application_number": "ANDA077646", "marketing_category": "ANDA", "marketing_start_date": "20140401", "listing_expiration_date": "20261231"}